Results for tag: "Sustained Release Injectable"

The Sustained Release Injectable market is a subset of the Infusions and Injectables market. It is composed of drugs that are administered via injection and are designed to provide a slow and steady release of the active ingredient over a period of time. This type of drug delivery system is beneficial for patients who require a consistent level of medication over a long period of time. It also reduces the number of injections needed, which can be beneficial for patients who have difficulty with frequent injections. The Sustained Release Injectable market is composed of a variety of drugs, including hormones, antibiotics, and analgesics. These drugs are typically administered via intramuscular or subcutaneous injection, and the active ingredient is slowly released over a period of time. Some companies in the Sustained Release Injectable market include Pfizer, Merck, Novartis, and Sanofi. These companies produce a variety of drugs that are designed to provide a slow and steady release of the active ingredient over a period of time. Show Less Read more